Immunohistochemistry (IHC) Global Market 2024 - By Size, Share, Technological Advancement, Competitive Landscape Forecast To 2033

Immunohistochemistry Market:WiseGuyReports.com adds “Global Immunohistochemistry Market Research Report 2020 Analysis and Forecast 2026” reports to its database.Executive SummaryGlobal Immunohistochemistry Market is valued approximately at USD 1.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2020-2026.

Immunohistochemical staining is extensively used in the diagnosis of abnormal cells such as found in cancerous tumors.

Specific molecular markers are traits of specific cellular events such as proliferation or death cell (apoptosis).

Further, immunohistochemistry is widely used in critical research to understand the circulation and localization of biomarkers and differentially expressed proteins in various parts of biological tissue.

according to the American Heart Association, there were around 17.6 million people died due to cardiovascular diseases in 2016, and a number is projected to grow to almost 23.6 million by 2030.

However, the high installation cost of IHC equipment, along with limited reimbursement are the few factors expected to limit the growth of the market over the forecast period of 2020-2026.Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5278117-global-immunohistochemistry-market-size-study-by-product-antibodiesThe regional analysis of global Immunohistochemistry market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.

The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.

It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.

Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.

Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.

Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.

Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size  By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.

The latest trending report Global Immunohistochemistry Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.

The report will assist reader with better understanding and decision making.The global Immunohistochemistry market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.7% in the forecast period of 2020 to 2025 and will expected to reach USD 1835.3 million by 2025, from USD 1414 million in 2019.The Immunohistochemistry market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/43428-immunohistochemistry-industry-market-reportThe major players covered in Immunohistochemistry are:Abcam plcPerkinElmer, Inc.Cell Signaling Technology, Inc.Agilent Technologies, Inc.Merck MilliporeBioSBF.

Hoffmann-La Roche LtdDanaherThermo Fisher Scientific Inc.By Type, Immunohistochemistry market has been segmented into:AntibodiesEquipmentReagentsKitsBy Application, Immunohistochemistry has been segmented into: DiagnosticsDrug TestingThe report offers in-depth assessment of the growth and other aspects of the Immunohistochemistry market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.

)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Immunohistochemistry Market @ https://www.decisiondatabases.com/contact/download-sample-43428The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Immunohistochemistry product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Immunohistochemistry, with price, sales, revenue and global market share of Immunohistochemistry in 2018 and 2019.Chapter 3, the Immunohistochemistry competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Immunohistochemistry breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Immunohistochemistry market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Immunohistochemistry sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Immunohistochemistry Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-43428Other Reports by DecisionDatabases.com: Global Flow Chemistry Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Global Flow Chemistry Reactors Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Global Metabolite Chemistry Reagents Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.

DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.

We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/News Source - https://www.industrynewsengine.com/2020/11/30/immunohistochemistry-market-report-till-2025-global-manufacturers-analysis/

The Global Companion Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.

The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.

The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on technology, application and end-user.

These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.

The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Companion Diagnostics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/16699-companion-diagnostics-market-reportThe report also covers the complete competitive landscape of the global Companion Diagnostics market with company profiles of key players such as:Abbott Laboratories, Inc.Agilent Technologies, Inc.BiomérieuxBiogenex LaboratoriesDanaher CorporationGe HealthcareMyriad Genetics, Inc.Qiagen N.V.Roche DiagnosticsThermo Fisher Scientific, Inc.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Technology:Polymerase Chain Reaction Test (PCR)Immunohistochemistry Test (IHC)In-Situ Hybridization Test (ISH)Others (Next-generation Sequencing, Multiplex Assay Test, Monoclonal Antibodies Test, and Cellular Immune Testing)By Applications:Breast CancerNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Melanoma CancerGastric CancerOthers (Neurology, Prostate Cancer, Ovarian Cancer, and Infectious Diseases)By End-User:Pharmaceutical CompaniesReference LaboratoriesOthers (Physicians, Hospitals, Academic Medical Centers, and Contract Research Organizations)By Geography:North America (NA)Europe (EU)Asia Pacific (APAC)Rest of the World (RoW)Download Free Sample Report of Global Companion Diagnostics Market @ https://www.decisiondatabases.com/contact/download-sample-16699The Global Companion Diagnostics Market has been exhibited in detail in the following chapters –Chapter 1 Companion Diagnostics Market PrefaceChapter 2 Executive SummaryChapter 3 Companion Diagnostics Industry AnalysisChapter 4 Companion Diagnostics Market Value Chain AnalysisChapter 5 Companion Diagnostics Market Analysis By TechnologyChapter 6 Companion Diagnostics Market Analysis By ApplicationsChapter 7 Companion Diagnostics Market Analysis By End-UserChapter 8 Companion Diagnostics Market Analysis By GeographyChapter 9 Competitive Landscape Of Companion Diagnostics CompaniesChapter 10 Company Profiles Of Companion Diagnostics IndustryPurchase the complete Global Companion Diagnostics Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-16699Other Reports by DecisionDatabases.com:Global Neurodiagnostics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Malaria Diagnostics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Influenza Diagnostics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.

DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.

Thus, CEA based diagnostic assays are used for the detection of such cancers and to check the treatment efficiency during the therapeutic period by a physician.In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030.

However, risk of infection and hematoma, lack of awareness and medical services in the developing countries will restrain the market growth during the assessment period.Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/772Global Carcinoembryonic Antigen Market - competitive AnalysisIn 2017, Aviva Systems Corporation (ASB), a protein solutions and application provider acquired GenWay Biotech, Inc. GenWay Biotech founded in 1998 has a multi-functional technology platform specialized in proteins and antibody solutions.

The antigens are highly pure ensuring no cross contamination with other cancer antigens.Global Carcinoembryonic Antigen Market - Regional Analysis North America leads the global carcinoembryonic antigen market owing to high prevalence of colorectal cancer, increasing obese population, lifestyle changes, and increasing acceptance of new technologies.

Moreover, increasing government support for research and development propels the market growth.

Factors such as advanced treatment facilities, rising skilled medical professionals and increasing prevalence of cancer drives the market within the region.

Moreover, developed healthcare infrastructure and rising number of skilled medical professionals fuels the regional market.Market PlayersSome of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC.TABLE OF CONTENTS REPORT PROLOGUE MARKET INTRODUCTION 2.1.

Global  Immunohistochemistry Market OverviewThe Global  Immunohistochemistry Market report draws accurate insights by examining the latest and prospective industry trends, helping the readers recognize the products and services that are boosting revenue growth and profitability.

The study performs a detailed analysis of all the significant factors impacting the market on a global and regional scale, including drivers, constraints, threats, challenges, prospects, and industry-specific trends.

This study assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.Check out the Sample Report here: https://www.reportsanddata.com/sample-enquiry-form/2198The  Immunohistochemistry market analysis is intended to provide all participants and vendors with pertinent specifics about growth aspects, roadblocks, threats, and lucrative business opportunities that the market is anticipated to reveal in the coming years.

This intelligence study also encompasses the revenue share, market size, production capacity, and rate of consumption to draw insights pertaining to the rivalry to gain control of a large portion of the market share.Leading Players in the  Immunohistochemistry Market:Abcam plc; Bio SB; Bio-Rad Laboratories Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; F. Hoffmann-La Roche AG; Merck KGaA;, Inc.; Thermo Fisher Scientific, Inc., PerkinElmer, Agilent TechnologiesCompetitive landscapeThe  Immunohistochemistry Industry is extremely competitive and consolidated because of the existence of several established companies that are adopting different marketing strategies in order to increase their market share.

The vendors are gradually expanding their focus on product personalization by way of customer interaction.

Immunohistochemistry Market segment by : Type (Revenue, USD Million; 2016–2026)AntibodiesEquipmentReagentsKitsApplication (Revenue, USD Million; 2016–2026)DiagnosticsCancerInfectious DiseasesCardiovascular DiseasesAutoimmune DiseasesDiabetes MellitusNephrological DiseasesDrug TestingEnd Use (Revenue, USD Million; 2016–2026)Hospitals and Diagnostic LaboratoriesClinicsResearch InstitutesOthers Regional  Immunohistochemistry Market (Regional Output, Demand & Forecast by Countries):-     North America (United States, Canada, Mexico)South America (Brazil, Argentina, Ecuador, Chile)Asia Pacific (China, Japan, India, Korea)Europe (Germany, UK, France, Italy)Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) and More.Connect with an expert for customization of Report : @ https://www.reportsanddata.com/request-customization-form/2198Points Covered in The Report:A.

The latest market intelligence study on the Immunohistochemistry market brings in the best of both qualitative and quantitative assessment techniques to explore the market size, share, and status of the Immunohistochemistry market for the forecast period, 2019 - 2026.

The extensive examination of the global business environment provides a detailed analysis of the key driving forces and challenges with the aim to give the stakeholders, business owners, and filed marketing executives a competitive advantage over others.

The study further probes into prominent challenges, technology advancements, current trends and lucrative avenues often considered as the boosting elements for the Immunohistochemistry market for the forecast period, 2013 - 2018.The top manufacturers covered in this reportAbcam plc; Agilent Technologies; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; Merck KGaA; PerkinElmer, Inc.; and Thermo Fisher Scientific, Inc.Immunohistochemistry (IHC) has crucial applications in the field of tissue distribution of antigens by using monoclonal and polyclonal antibodies.

It is used for cancer diagnosis, because it determines the presence of tumor antigens.

It is a technique which combines immunological, anatomical, and biochemical processes to identify tissue components by the interaction of target antigens with specific antibodies that are tagged by a label.

Immunohistochemistry used by public and private organizations to check localization and distribution of cellular components within the cells.Download Free Sample PDF Copy of this Report@ https://www.reportsanddata.com/sample-enquiry-form/2198Type (Revenue, USD Million; 2016–2026)AntibodiesPrimary AntibodiesSecondary AntibodiesEquipmentSlide Staining SystemsTissue MicroarraysTissue Processing SystemsSlide ScannersOthersReagentsHistological StainsBlocking Sera and ReagentsChromogenic SubstratesFixation ReagentsStabilizersOrganic SolventsProteolytic EnzymesDiluentsKitsApplication (Revenue, USD Million; 2016–2026)DiagnosticsCancerInfectious DiseasesCardiovascular DiseasesAutoimmune DiseasesDiabetes MellitusNephrological DiseasesDrug TestingEnd Use (Revenue, USD Million; 2016–2026)Hospitals and Diagnostic LaboratoriesClinicsResearch InstitutesOthersDealing with the competition and competitorsThe subject matter experts conducting the study offer a deep understanding of how prominent leaders have managed to navigate the potential buyers and competitive dynamics influencing their brand positioning in the industry The Immunohistochemistry market analysis provides everything a business owner needs in order to succeed.Here are the questions we answer...What are the future opportunities in store for the vendors operating in the Immunohistochemistry market?What does the competitive landscape look like?Which emerging technologies are believed to impact the Immunohistochemistry market performance?What are the key trends and dynamics?Which regulations that will impact the industry?Which segment will offer the most opportunity for growth between 2019 and 2026?Where will most developments take place in the long term?Who are the most prominent vendors and how much market share do they occupy?What are the latest technologies or discoveries influencing the Immunohistochemistry market growth worldwide?We can also provide the customized separate regional or country-level reports, for the following regions:North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & AfricaHelping you establish a strong foothold in the industryThe Immunohistochemistry report highlights set of information related to pricing and the category of customers who are more than willing to pay for certain products and services.

Global Immunohistochemistry (IHC) Market ReportThe ‘Global Immunohistochemistry (IHC) Market Insights, Forecast to 2027’ offers a comprehensive evaluation of the Immunohistochemistry (IHC) market on the global scale and sheds light on the growth opportunities and prospects to help readers formulate strategic plans.

The report offers information on the overall market trends and analyzes historical data to offer accurate forecast estimations.

The report also provides insightful data about market capacities, technological advancements, R developments, and other key features.The report is furnished with the latest market scenario and financial condition pertaining to the after-effects of the COVID-19 pandemic.

The report also studies the impact of the COVID-19 pandemic on the global supply chains and economic scenario of the industry.

It considers the COVID-19 pandemic as a key factor influencing the growth of the Immunohistochemistry (IHC) market.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2198Key Manufacturers in the Global Immunohistochemistry (IHC) Market:Abcam plc; Agilent Technologies; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; Merck KGaA; PerkinElmer, Inc.; and Thermo Fisher Scientific, Inc.Scope of the Immunohistochemistry (IHC) Market Report:The report offers an extensive assessment of the growth rate and the market size based on the dynamics of the industry and the factors influencing the growth of the market.

The report is formulated through authentic sources and verified and validated by industry experts.

Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.

These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.

According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.

The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.

The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.

Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.